Gamma-aminobutyric acid supplementation combined with gonadotropin-releasing hormone analog therapy versus gonadotropin-releasing hormone analog therapy alone for linear growth in children with growth retardation: a retrospective cohort study.

Transl Pediatr · 2026 · PMC13351637 · PMID 42433946

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

GV improvements at 6–12 months were also uniform across most subgroups, although a nominally significant interaction was observed for AEs (P interaction=0.02), with patients without AEs showing slightly larger GV improvements (1.316 vs. 0.792 cm/year).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.